Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hilgard

Showing results (71-80 of 135) with videos related to

Pageof 14
Sort By:
Cancer Treatment Reviews|September 1, 1985
Oxazaphosphorines as biological response modifiers--experimental and clinical perspectivesP Hilgard, J Pohl, J Stekar, et al.
Cancer Treatment Reviews|December 1, 1987
Anticancer drugs: estrophilic cisplatin derivativesJ Engel, H Schönenberger, F Lux, et al.
European Journal of Biochemistry|August 1, 1995
Selection and characterization of mammalian cell lines with stable over-expression of human pituitary receptors for gonadoliberinT Beckers, K Marheineke, H Reiländer, et al.
Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|July 1, 1970
[Studies on thromboplastin activity, fibrinolysis and uptake of radioactive iodine-labeled fibrinogen in various experimental tumors]P Hilgard, H Heyes, E Sigmund, et al.
Schweizerische Medizinische Wochenschrift|April 3, 1971
[Intravascular coagulation in solid Walker carcinosarcoma 256]P Hilgard, R Ziegler, H Minne, et al.
Cancer Treatment Reviews|June 1, 1982
Etoposide--chemistry, preclinical and clinical pharmacologyW Achterrath, N Niederle, R Raettig, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1989
Evidence of a role for NK cells in oxazaphosphorine-mediated tumor regressionT Reissmann, P Hilgard, R Voegeli, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1971
[Generalised paraneoplastic calcinosis due to the Walker-carcinosarcoma of the rat (author's transl)]W Schmitt, P Hilgard, R Ziegler, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Alkylphosphocholines: a new class of membrane-active anticancer agentsP Hilgard, T Klenner, J Stekar, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Augmentation of host antitumor immunity by low doses of cyclophosphamide and mafosfamide in two animal tumor modelsT Reissmann, R Voegeli, J Pohl, et al.
Pageof 14

Showing results (71-80 of 135) with videos related to

Sort By:
Pageof 14
Cancer Treatment Reviews|September 1, 1985
Oxazaphosphorines as biological response modifiers--experimental and clinical perspectivesP Hilgard, J Pohl, J Stekar, et al.
Cancer Treatment Reviews|December 1, 1987
Anticancer drugs: estrophilic cisplatin derivativesJ Engel, H Schönenberger, F Lux, et al.
European Journal of Biochemistry|August 1, 1995
Selection and characterization of mammalian cell lines with stable over-expression of human pituitary receptors for gonadoliberinT Beckers, K Marheineke, H Reiländer, et al.
Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|July 1, 1970
[Studies on thromboplastin activity, fibrinolysis and uptake of radioactive iodine-labeled fibrinogen in various experimental tumors]P Hilgard, H Heyes, E Sigmund, et al.
Schweizerische Medizinische Wochenschrift|April 3, 1971
[Intravascular coagulation in solid Walker carcinosarcoma 256]P Hilgard, R Ziegler, H Minne, et al.
Cancer Treatment Reviews|June 1, 1982
Etoposide--chemistry, preclinical and clinical pharmacologyW Achterrath, N Niederle, R Raettig, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1989
Evidence of a role for NK cells in oxazaphosphorine-mediated tumor regressionT Reissmann, P Hilgard, R Voegeli, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1971
[Generalised paraneoplastic calcinosis due to the Walker-carcinosarcoma of the rat (author's transl)]W Schmitt, P Hilgard, R Ziegler, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Alkylphosphocholines: a new class of membrane-active anticancer agentsP Hilgard, T Klenner, J Stekar, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Augmentation of host antitumor immunity by low doses of cyclophosphamide and mafosfamide in two animal tumor modelsT Reissmann, R Voegeli, J Pohl, et al.
Pageof 14